Cargando…
Renal Cell Carcinoma Unclassified with Medullary Phenotype in a Patient with Neurofibromatosis Type 2
We present, to our knowledge, the first reported case of germline neurofibromatosis Type 2 (NF2) associated with renal cell carcinoma unclassified with medullary phenotype (RCCU-MP) with somatic loss by immunohistochemistry of the SMARCB1 tumor suppressor gene located centromeric to NF2 on chromosom...
Autores principales: | Sarkar, Sanila, Throckmorton, Whitney, Bingham, Racheal, Msaouel, Pavlos, Genovese, Giannicola, Slopis, John, Rao, Priya, Sadighi, Zsila, Herzog, Cynthia E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047671/ https://www.ncbi.nlm.nih.gov/pubmed/36975468 http://dx.doi.org/10.3390/curroncol30030255 |
Ejemplares similares
-
Molecular hallmarks of renal medullary carcinoma: more to c-MYC than meets the eye
por: Msaouel, Pavlos, et al.
Publicado: (2020) -
NFB-06. TREATMENT CHALLENGES IN PEDIATRIC GLIOBLASTOMA MULTIFORME WITH CONCURRENT SOMATIC AND GERMLINE NF1 MUTATIONS WITH GERMLINE MISMATCH REPAIR MUTATIONS: TWO UNIQUE CASES
por: Baig, Muhammed, et al.
Publicado: (2020) -
Targeting proteostasis and autophagy in SMARCB1-deficient malignancies: where next?
por: Msaouel, Pavlos, et al.
Publicado: (2019) -
Efficacy and Safety of Bevacizumab Plus Erlotinib in Patients with Renal Medullary Carcinoma
por: Wiele, Andrew J., et al.
Publicado: (2021) -
Case Report: Unclassified Renal Cell Carcinoma With Medullary Phenotype and SMARCB1/INI1 Deficiency, Broadening the Spectrum of Medullary Carcinoma
por: Valeri, Marina, et al.
Publicado: (2022)